Detalhe da pesquisa
1.
Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.
Malar J
; 23(1): 61, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418982
2.
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Malar J
; 23(1): 145, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741094
3.
Defining the next generation of severe malaria treatment: a target product profile.
Malar J
; 23(1): 174, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835069
4.
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Malar J
; 22(1): 2, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597076
5.
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study.
Br J Clin Pharmacol
; 89(3): 1187-1197, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199201
6.
Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
Clin Infect Dis
; 74(2): 180-188, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983371
7.
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 229-241, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650326
8.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 215-228, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650322
9.
Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
PLoS Med
; 18(6): e1003669, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129601
10.
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
Malar J
; 20(1): 214, 2021 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964945
11.
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data.
PLoS Med
; 17(3): e1003040, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134952
12.
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.
Pharmacogenet Genomics
; 30(7): 161-165, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433338
13.
Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932368
14.
Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
Malar J
; 19(1): 111, 2020 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32169086
15.
Partnering to fight malaria in India: Past, present and future.
J Vector Borne Dis
; 56(1): 15-24, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31070161
16.
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
J Infect Dis
; 217(5): 693-702, 2018 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216395
17.
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
Clin Infect Dis
; 66(12): 1823-1830, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29293893
18.
Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30201820
19.
A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria.
Malar J
; 17(1): 462, 2018 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526594
20.
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria.
Malar J
; 17(1): 402, 2018 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30384848